139 related articles for article (PubMed ID: 25168846)
1. Prognostic value of the ankle-brachial index in patients undergoing drug-eluting stent implantation.
Kim HL; Seo JB; Chung WY; Zo JH; Kim MA; Kim SH
J Atheroscler Thromb; 2015; 22(1):27-37. PubMed ID: 25168846
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of an abnormal ankle-brachial index in patients receiving drug-eluting stents.
Ribera A; Ferreira-González I; Marsal JR; Cascant P; Permanyer-Miralda G; Abdul-Jawad O; Iñigo-Garcia LA; Guarinos-Oltra J; Cequier A; Goicolea-Güemez L; García-Del-Blanco B; Martí G; García-Dorado D
Am J Cardiol; 2011 Nov; 108(9):1225-31. PubMed ID: 21872197
[TBL] [Abstract][Full Text] [Related]
3. Different calculations of ankle-brachial index and their impact on cardiovascular risk prediction.
Espinola-Klein C; Rupprecht HJ; Bickel C; Lackner K; Savvidis S; Messow CM; Munzel T; Blankenberg S;
Circulation; 2008 Aug; 118(9):961-7. PubMed ID: 18697822
[TBL] [Abstract][Full Text] [Related]
4. Low ankle brachial index predicts poor outcomes including target lesion revascularization during the long-term follow up after drug-eluting stent implantation for coronary artery disease.
Sasaki M; Mitsutake Y; Ueno T; Fukami A; Sasaki KI; Yokoyama S; Ohtsuka M; Nakayoshi T; Itaya N; Chibana H; Sasaki M; Ishimatsu T; Kagiyama K; Fukumoto Y
J Cardiol; 2020 Mar; 75(3):250-254. PubMed ID: 31455545
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Value of Brachial-Ankle Pulse Wave Velocity in Patients With Takayasu Arteritis With Drug-Eluting Stent Implantation.
Wang X; Dang A
Arthritis Care Res (Hoboken); 2015 Aug; 67(8):1150-7. PubMed ID: 25708244
[TBL] [Abstract][Full Text] [Related]
6. Serum alkaline phosphatase is a predictor of mortality, myocardial infarction, or stent thrombosis after implantation of coronary drug-eluting stent.
Park JB; Kang DY; Yang HM; Cho HJ; Park KW; Lee HY; Kang HJ; Koo BK; Kim HS
Eur Heart J; 2013 Mar; 34(12):920-31. PubMed ID: 23242189
[TBL] [Abstract][Full Text] [Related]
7. Predictive Value of Combining the Ankle-Brachial Index and SYNTAX Score for the Prediction of Outcome After Percutaneous Coronary Intervention (from the SHINANO Registry).
Ueki Y; Miura T; Miyashita Y; Motoki H; Shimada K; Kobayashi M; Nakajima H; Kimura H; Akanuma H; Mawatari E; Sato T; Hotta S; Kamiyoshi Y; Maruyama T; Watanabe N; Eisawa T; Aso S; Uchikawa S; Hashizume N; Sekimura N; Morita T; Ebisawa S; Izawa A; Koyama J; Ikeda U
Am J Cardiol; 2016 Jan; 117(2):179-85. PubMed ID: 26684515
[TBL] [Abstract][Full Text] [Related]
8. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
JACC Cardiovasc Interv; 2013 Dec; 6(12):1242-9. PubMed ID: 24355114
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and clinical implications of newly revealed, asymptomatic abnormal ankle-brachial index in patients with significant coronary artery disease.
Lee JY; Lee SW; Lee WS; Han S; Park YK; Kwon CH; Jang JY; Cho YR; Park GM; Ahn JM; Kim WJ; Park DW; Kang SJ; Kim YH; Lee CW; Park SW; Park SJ
JACC Cardiovasc Interv; 2013 Dec; 6(12):1303-13. PubMed ID: 24355120
[TBL] [Abstract][Full Text] [Related]
10. The prognostic utility of the SYNTAX score on 1-year outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial.
Garg S; Serruys PW; Silber S; Wykrzykowska J; van Geuns RJ; Richardt G; Buszman PE; Kelbæk H; van Boven AJ; Hofma SH; Linke A; Klauss V; Wijns W; Macaya C; Garot P; DiMario C; Manoharan G; Kornowski R; Ischinger T; Bartorelli A; Van Remortel E; Ronden J; Windecker S
JACC Cardiovasc Interv; 2011 Apr; 4(4):432-41. PubMed ID: 21511223
[TBL] [Abstract][Full Text] [Related]
11. Stent thrombosis, clinical events, and influence of prolonged clopidogrel use after placement of drug-eluting stent data from an observational cohort study of drug-eluting versus bare-metal stents.
Park DW; Yun SC; Lee SW; Kim YH; Lee CW; Hong MK; Cheong SS; Kim JJ; Park SW; Park SJ
JACC Cardiovasc Interv; 2008 Oct; 1(5):494-503. PubMed ID: 19463351
[TBL] [Abstract][Full Text] [Related]
12. Clinical presentation and outcomes of coronary in-stent restenosis across 3-stent generations.
Magalhaes MA; Minha S; Chen F; Torguson R; Omar AF; Loh JP; Escarcega RO; Lipinski MJ; Baker NC; Kitabata H; Ota H; Suddath WO; Satler LF; Pichard AD; Waksman R
Circ Cardiovasc Interv; 2014 Dec; 7(6):768-76. PubMed ID: 25466551
[TBL] [Abstract][Full Text] [Related]
13. Correlates and outcomes of late and very late drug-eluting stent thrombosis: results from DESERT (International Drug-Eluting Stent Event Registry of Thrombosis).
Waksman R; Kirtane AJ; Torguson R; Cohen DJ; Ryan T; Räber L; Applegate R; Waxman S; Gordon P; Kaneshige K; Leon MB;
JACC Cardiovasc Interv; 2014 Oct; 7(10):1093-102. PubMed ID: 25240540
[TBL] [Abstract][Full Text] [Related]
14. Long-Term Outcomes After Coronary Stent Implantation in Patients Presenting With Versus Without Acute Myocardial Infarction (an Observation from Coronary Revascularization Demonstrating Outcome Study-Kyoto Registry Cohort-2).
Yamaji K; Natsuaki M; Morimoto T; Ono K; Furukawa Y; Nakagawa Y; Kadota K; Ando K; Shirai S; Watanabe H; Shiomi H; Kimura T
Am J Cardiol; 2015 Jul; 116(1):15-23. PubMed ID: 26068701
[TBL] [Abstract][Full Text] [Related]
15. The prognosis of diabetic patients with high ankle-brachial index depends on the coexistence of occlusive peripheral artery disease.
Aboyans V; Lacroix P; Tran MH; Salamagne C; Galinat S; Archambeaud F; Criqui MH; Laskar M
J Vasc Surg; 2011 Apr; 53(4):984-91. PubMed ID: 21215587
[TBL] [Abstract][Full Text] [Related]
16. Impact of chronic kidney disease on long-term clinical outcomes after percutaneous coronary intervention with drug-eluting or bare-metal stents.
Kersting S; Grumann T; Hummel J; Hauschke D; Bode C; Hehrlein C
Crit Pathw Cardiol; 2012 Sep; 11(3):152-9. PubMed ID: 22825536
[TBL] [Abstract][Full Text] [Related]
17. Long-term prognostic value of preprocedural C-reactive protein after drug-eluting stent implantation.
Delhaye C; Maluenda G; Wakabayashi K; Ben-Dor I; Lemesle G; Collins SD; Syed AI; Torguson R; Kaneshige K; Xue Z; Suddath WO; Satler LF; Kent KM; Lindsay J; Pichard AD; Waksman R
Am J Cardiol; 2010 Mar; 105(6):826-32. PubMed ID: 20211326
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
Dangas GD; Serruys PW; Kereiakes DJ; Hermiller J; Rizvi A; Newman W; Sudhir K; Smith RS; Cao S; Theodoropoulos K; Cutlip DE; Lansky AJ; Stone GW
JACC Cardiovasc Interv; 2013 Sep; 6(9):914-22. PubMed ID: 24050859
[TBL] [Abstract][Full Text] [Related]
19. The unrestricted use of sirolimus- and paclitaxel-eluting stents results in better clinical outcomes during 6-year follow-up than bare-metal stents: an analysis of the RESEARCH (Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated At Rotterdam Cardiology Hospital) registries.
Simsek C; Magro M; Boersma E; Onuma Y; Nauta ST; Gaspersz MP; van der Giessen WJ; van Domburg RT; Serruys PW;
JACC Cardiovasc Interv; 2010 Oct; 3(10):1051-8. PubMed ID: 20965464
[TBL] [Abstract][Full Text] [Related]
20. Incidence and outcome of surgical procedures after coronary bare-metal and drug-eluting stent implantation: a report from the CREDO-Kyoto PCI/CABG registry cohort-2.
Tokushige A; Shiomi H; Morimoto T; Furukawa Y; Nakagawa Y; Kadota K; Iwabuchi M; Shizuta S; Tada T; Tazaki J; Kato Y; Hayano M; Abe M; Ehara N; Inada T; Kaburagi S; Hamasaki S; Tei C; Nakashima H; Ogawa H; Tatami R; Suwa S; Takizawa A; Nohara R; Fujiwara H; Mitsudo K; Nobuyoshi M; Kita T; Kimura T;
Circ Cardiovasc Interv; 2012 Apr; 5(2):237-46. PubMed ID: 22396582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
